About Conference
The Organizing Committee is delighted to invite you to attend the 13th Asian Biologics and Biosimilars Congress one of its remarkable Pharmaceutical conferences, to be held during August 20-22, 2019 at Melbourne, Australia. Asian Biosimilars Congress 2019 brings together scientists, researchers and CROs from around the world. With the approval of second biosimilar by the USFDA-Inflectra, the biosimilars market is owned to experience an exponential growth over the coming few years. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.
At Asian Biosimilars 2019 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community.
Why to attend???
Join your peers around the world focused on learning about Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 3-day event. World-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.
Target Audience:
- Directors, CEO’s of Organizations
- Business Development Managers
- Chief Scientific Officers
- R&D Researchers from Biosimilar and Biologics Industries
- Professors, Associate Professors, Assistant Professors
- PhD Scholars
- Patent Attorneys
- Intellectual Property Attorneys
- Investment Analysts
- Association, Association presidents and professionals
- Noble laureates in Health Care and Medicine
- Bio instruments Professionals
- Bio-informatics Professionals
- Software development companies
- Research Institutes and members
- Supply Chain companies
- Manufacturing Companies
- CRO and DATA management Companies
- Training Institutes
- Business Entrepreneurs
Audience Share:
Industry 60%
Academia 30%
Others 10%
Conference Highlights
- Latest Biosimilars in Asian Scenario
- Regulatory Approach for Biosimilars
- Challenges in Developing Biosimilars
- Biosimilar Market and Cost Analysis
- Pharmacovigilance of Biosimilars
- Biosimilars Research Pipeline
- Globalization of Biosimilars
- Emerging Trends in Biosimilars
- Clinical Studies on Biosimilars
- Emerging Biosimilars in Therapeutics
- Biosimilars Analytical Strategies
- Legal Issues and BPCI Act
- Intellectual Property Rights
- Brexit Effect on Biosimilars
- BCS & IVIVC Based Biowaivers
- Biosimilar Companies and Market Analysis
- Bioequivalence Assessment
- Entrepreneurs Investment Meet
Special Issues
- All accepted abstracts will be published in respective Supported International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref
